Dasatinib: From Treatment of Imatinib-Resistant or -Intolerant Patients With Chronic Myeloid Leukemia to Treatment of Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Autor: Abbott, Brian L.
Zdroj: In Clinical Therapeutics February 2012 34(2):272-281
Databáze: ScienceDirect